Lactase Enzyme Market Is Projected To Evolve At 4% CAGR And Account For US$ 1.1 Billion By 2033, Fact.MR

The global lactase enzymes market is projected to grow at a compound annual growth rate (CAGR) of 4% from 2023 to 2033, reaching a market value of US$ 1.1 billion by the end of 2033. In 2023, global sales of lactase enzymes are anticipated to total US$ 742 million.

The increasing incidence of lactose intolerance worldwide, coupled with the rising demand for lactose-free products, is a key driver of this market growth. In recent years, there has been a significant increase in cases of lactose intolerance globally.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=666

According to the World Population Review, approximately 65% of the adult human population suffers from lactose intolerance due to decreasing activity of the LCT gene. This trend is expected to continue fueling the development of the global lactase enzyme market.

Individuals with lactose intolerance are unable to fully digest lactose found in dairy products, leading to conditions such as diarrhea and bloating. To address this issue, lactase enzyme is being increasingly utilized in industries such as food and beverage, pharmaceuticals, and dietary supplements.

Lactase is primarily used in food and beverage applications to reduce or eliminate lactose content in dairy products, making them suitable for lactose-intolerant individuals. By breaking down lactose, lactase helps prevent symptoms like diarrhea, pain, cramping, gas, and bloating. This enzyme allows people who are lactose intolerant to enjoy dairy products without adverse effects.

The demand for lactase is driven by factors such as the growing preference for easily digestible foods, increasing health awareness, and its rising use in dietary supplements. Additionally, the expanding production and consumption of lactase tablets to promote health will create lucrative opportunities for manufacturers over the next decade.

The food and beverage sector remains a significant market for lactase enzymes due to their extensive use in producing lactose-free products. In 2020, this sector accounted for 46% of the global lactase industry, and this share is expected to increase during the forecast period due to the rising demand for lactose-free processed foods.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:
• Based on product type, fungal lactase enzymes segment held a market share of 78% in 2022.
• By form, liquid lactase enzyme sales are projected to rise at 3.8% CAGR during the forecast period.
• Canada's lactase enzyme market is forecast to expand at 4.8% CAGR between 2023 and 2033.
• Lactase enzyme sales in the USA are expected to surge at 3.5% CAGR over the next decade.
• With increasing demand for easy-to-digest foods, Japan's lactase enzyme market is set to progress by 6% CAGR during the forecast period.
• Germany accounts for 16% of Europe's lactase enzyme market and is projected to accelerate at 2.3% CAGR from 2023 to 2033.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭
• Symrise AG
• DSM Chemicals
• Chr. Hansen Holding A/S
• Biolaxi Corp.
• Novact Corp.
• Advanced Enzyme Technologies Limited
• DuPont de Nemours and Company
• Merck KGaA (Sigma-Aldrich)
• Natural Factors Nutritional Products Ltd.
• Mitushi Biopharma
• Novozymes A/S
• Sternenzyme
• Infinita Biotech Pvt. Ltd.
• Calza Clemente
• Senson
• Nature BioScience Pvt. Ltd.
• Aumgene Biosciences

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:
The global lactase enzyme industry is set to benefit from the increasing interest in enzyme-based foods due to their numerous health benefits. Rising awareness about lactose intolerance is projected to boost lactase enzyme sales throughout the forecast period. The increasing number of start-ups introducing innovative products is expected to drive the development of the global lactase enzyme market over the next decade. Enhanced investments in research and development aimed at expanding the application scope of lactase enzymes will offer lucrative opportunities for manufacturers.

Restraints:
Fluctuating enzyme costs are hindering growth in the global lactase enzyme market. The growing popularity of plant-based dairy products is also likely to limit market expansion to some extent.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞
Lactase enzyme companies are investing in the expansion of their research and development scope to increase the scope of application as many manufacturers are incorporating lactase enzymes in their product portfolio.

• In June 2022, Provilac, a milk delivery firm in India announced the launch of its lactose-free cow milk offering. The company aims to expand its offerings and increase its market share in India by 10 to 20 percent over the coming years.
• In August 2021, Good Culture, a cultured foods brand based in the United States announced the launch of its new line of lactose-free products. The product range includes lactose-free cottage cheese and lactose-free sour cream containing lactase enzymes.
• In March 2020, Novozymes, a leading name in the global lactase enzyme industry landscape announced the launch of Saphera Fiber. The newly launched product was a lactase enzyme capable of reducing sugar content in dairy products while increasing fiber.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐋𝐚𝐜𝐭𝐚𝐬𝐞 𝐄𝐧𝐳𝐲𝐦𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡
• By Product Type:
o Fungal Lactase Enzymes
o Neutral Lactase Enzymes

• By Form:
o Dry
o Liquid

• By End Use:
o Food & Beverages
o Dietary Supplements
o Pharmaceuticals

• By Region:
o North America
o Latin America
o Europe
o APAC
o MEA

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.factmr.com/report/666/lactase-enzyme-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.